Cargando…
Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130680/ https://www.ncbi.nlm.nih.gov/pubmed/35649743 http://dx.doi.org/10.1016/j.arcmed.2022.05.005 |
| _version_ | 1784713022119346176 |
|---|---|
| author | Zhou, Si-Yu Shu, Wen-Jing Pan, Hai-Feng |
| author_facet | Zhou, Si-Yu Shu, Wen-Jing Pan, Hai-Feng |
| author_sort | Zhou, Si-Yu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9130680 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91306802022-05-25 Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic Zhou, Si-Yu Shu, Wen-Jing Pan, Hai-Feng Arch Med Res Letter to the Editor Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. 2022-07 2022-05-25 /pmc/articles/PMC9130680/ /pubmed/35649743 http://dx.doi.org/10.1016/j.arcmed.2022.05.005 Text en © 2022 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Zhou, Si-Yu Shu, Wen-Jing Pan, Hai-Feng Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic |
| title | Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic |
| title_full | Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic |
| title_fullStr | Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic |
| title_full_unstemmed | Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic |
| title_short | Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic |
| title_sort | reply to: utility of serum s100b as a marker in sle patients during and after the sars-cov-2 pandemic |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130680/ https://www.ncbi.nlm.nih.gov/pubmed/35649743 http://dx.doi.org/10.1016/j.arcmed.2022.05.005 |
| work_keys_str_mv | AT zhousiyu replytoutilityofserums100basamarkerinslepatientsduringandafterthesarscov2pandemic AT shuwenjing replytoutilityofserums100basamarkerinslepatientsduringandafterthesarscov2pandemic AT panhaifeng replytoutilityofserums100basamarkerinslepatientsduringandafterthesarscov2pandemic |